Takeda Pharmaceutical Co Ltd (TAK)
13.38
+0.05
(+0.38%)
USD |
NYSE |
Nov 22, 16:00
13.37
-0.01
(-0.07%)
After-Hours: 20:00
Takeda Pharmaceutical Price: 13.38 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 13.30 | 13.42 | 13.30 | 13.38 | 1.558M |
Nov 21, 2024 | 13.28 | 13.35 | 13.24 | 13.33 | 4.011M |
Nov 20, 2024 | 13.48 | 13.48 | 13.21 | 13.29 | 3.779M |
Nov 19, 2024 | 13.56 | 13.63 | 13.53 | 13.62 | 1.679M |
Nov 18, 2024 | 13.56 | 13.64 | 13.53 | 13.53 | 3.791M |
Nov 15, 2024 | 13.61 | 13.68 | 13.50 | 13.62 | 2.197M |
Nov 14, 2024 | 13.53 | 13.75 | 13.52 | 13.57 | 2.323M |
Nov 13, 2024 | 13.53 | 13.60 | 13.46 | 13.56 | 1.745M |
Nov 12, 2024 | 13.61 | 13.64 | 13.52 | 13.54 | 1.004M |
Nov 11, 2024 | 13.65 | 13.72 | 13.64 | 13.65 | 1.310M |
Nov 08, 2024 | 13.76 | 13.86 | 13.72 | 13.78 | 984229.0 |
Nov 07, 2024 | 13.84 | 13.90 | 13.80 | 13.86 | 1.037M |
Nov 06, 2024 | 13.99 | 13.99 | 13.72 | 13.79 | 1.205M |
Nov 05, 2024 | 14.04 | 14.24 | 14.04 | 14.22 | 908620.0 |
Nov 04, 2024 | 13.95 | 14.11 | 13.94 | 14.05 | 1.539M |
Nov 01, 2024 | 14.00 | 14.06 | 13.94 | 13.96 | 811765.0 |
Oct 31, 2024 | 13.91 | 13.98 | 13.84 | 13.94 | 1.312M |
Oct 30, 2024 | 13.77 | 13.90 | 13.77 | 13.89 | 1.296M |
Oct 29, 2024 | 13.67 | 13.88 | 13.67 | 13.85 | 1.551M |
Oct 28, 2024 | 13.54 | 13.64 | 13.50 | 13.60 | 1.889M |
Oct 25, 2024 | 13.67 | 13.74 | 13.54 | 13.57 | 1.595M |
Oct 24, 2024 | 13.83 | 13.86 | 13.78 | 13.80 | 811757.0 |
Oct 23, 2024 | 13.95 | 13.99 | 13.80 | 13.86 | 1.338M |
Oct 22, 2024 | 14.10 | 14.14 | 14.06 | 14.13 | 978505.0 |
Oct 21, 2024 | 14.29 | 14.32 | 14.14 | 14.15 | 1.090M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
12.42
Minimum
Oct 19 2022
20.72
Maximum
Nov 26 2019
15.74
Average
15.32
Median
Price Benchmarks
HUTCHMED (China) Ltd | 17.36 |
Astellas Pharma Inc | 10.09 |
Nxera Pharma Co Ltd | 8.052 |
PeptiDream Inc | 17.00 |
Healios KK | 1.20 |
Price Related Metrics
PE Ratio | 22.14 |
PS Ratio | 1.413 |
PEG Ratio | 0.6128 |
Price to Book Value | 0.8754 |
Price to Free Cash Flow | 12.39 |
Earnings Yield | 4.52% |
Market Cap | 42.42B |
PEGY Ratio | 0.544 |
Operating PE Ratio | 13.59 |
Normalized PE Ratio | 22.14 |